Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2017

01.07.2017 | Basic Science

Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis

verfasst von: Hai-Tao Du, Ling-Ling Du, Xian-Ling Tang, Hong-Yan Ge, Ping Liu

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the roles of a selective MMP-2 and -9 inhibitor (SB-3CT) in corneal inflammatory lymphangiogenesis.

Methods

The expression of MMP-2 and -9 in the cornea after suture inplacement, treated with SB-3CT or negative control, was detected by real-time polymerase chain reaction (PCR). Inflammatory corneal neovascularization (NV) was induced by corneal suture placement. Mice were treated with SB-3CT eye drops (twice daily for 1 week, 5 μL per drop; 50, 100, or 200 μM). The outgrowth of blood and lymphatic vessels, and macrophage recruitment were analyzed by immunofluorescence assay. The expressions of vascular endothelial growth factor-C (VEGF-C) and its receptor VEGFR-3 were tested by real-time PCR.

Results

MMP-2 and -9 expression were suppressed significantly by treatment with SB-3CT. The data demonstrated, for the first time, that SB-3CT strongly reduced corneal lymphangiogenesis and macrophage infiltration during inflammation. Furthermore, expressions of VEGF-C and its receptor VEGFR-3 were significantly inhibited by SB-3CT during corneal lymphangiogenesis.

Conclusions

These novel findings indicated that blockade of MMP-2 and -9 could inhibit lymphangiogenesis. Further investigation of this factor may provide novel therapies for transplant rejection and other lymphatic disorders.
Literatur
1.
Zurück zum Zitat Ji RC (2006) Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol 4:83–100CrossRefPubMed Ji RC (2006) Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol 4:83–100CrossRefPubMed
2.
Zurück zum Zitat Hirakawa S, Detmar M (2004) New insights into the biology and pathology of the cutaneous lymphatic system. J Dermatol Sci 35:1–8CrossRefPubMed Hirakawa S, Detmar M (2004) New insights into the biology and pathology of the cutaneous lymphatic system. J Dermatol Sci 35:1–8CrossRefPubMed
3.
Zurück zum Zitat He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S et al (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65:4739–4746CrossRefPubMed He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S et al (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65:4739–4746CrossRefPubMed
4.
Zurück zum Zitat Hosseini H, Nejabat M (2007) A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents. Med Hypotheses 68:799–801CrossRefPubMed Hosseini H, Nejabat M (2007) A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents. Med Hypotheses 68:799–801CrossRefPubMed
5.
Zurück zum Zitat Dietrich T, Bock F, Yuen D, Hos D, Bachmann BO, Zahn G et al (2010) Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol 184:535–539CrossRefPubMed Dietrich T, Bock F, Yuen D, Hos D, Bachmann BO, Zahn G et al (2010) Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol 184:535–539CrossRefPubMed
6.
Zurück zum Zitat Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174CrossRefPubMed Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174CrossRefPubMed
7.
Zurück zum Zitat McCawley LJ, Matrisian LM (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6:149–156CrossRefPubMed McCawley LJ, Matrisian LM (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6:149–156CrossRefPubMed
8.
Zurück zum Zitat Ma DH, Chen JK, Zhang F, Lin KY, Yao JY, Yu JS (2006) Regulation of corneal angiogenesis in limbal stem cell deficiency. Prog Retin Eye Res 25:563–590CrossRefPubMed Ma DH, Chen JK, Zhang F, Lin KY, Yao JY, Yu JS (2006) Regulation of corneal angiogenesis in limbal stem cell deficiency. Prog Retin Eye Res 25:563–590CrossRefPubMed
9.
Zurück zum Zitat Saika S (2007) Yin and yang in cytokine regulation of corneal wound healing: roles of TNF-alpha. Cornea 26:S70–S74CrossRefPubMed Saika S (2007) Yin and yang in cytokine regulation of corneal wound healing: roles of TNF-alpha. Cornea 26:S70–S74CrossRefPubMed
10.
12.
Zurück zum Zitat Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al (2000) Matrix metalloproteinase 9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744CrossRefPubMedPubMedCentral Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al (2000) Matrix metalloproteinase 9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bruyere F, Melen-Lamalle L, Blacher S, Roland G, Thiry M, Moons L et al (2008) Modeling lymphangiogenesis in a three-dimensional culture system. Nat Methods 5:431–437CrossRefPubMed Bruyere F, Melen-Lamalle L, Blacher S, Roland G, Thiry M, Moons L et al (2008) Modeling lymphangiogenesis in a three-dimensional culture system. Nat Methods 5:431–437CrossRefPubMed
14.
Zurück zum Zitat Nakamura ES, Koizumi K, Kobayashi M, Saiki I (2004) Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270. Cancer Sci 95:25–31CrossRefPubMed Nakamura ES, Koizumi K, Kobayashi M, Saiki I (2004) Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270. Cancer Sci 95:25–31CrossRefPubMed
15.
Zurück zum Zitat Ikejiri M, Bernardo MM, Bonfil RD, Toth M, Chang M, Fridman R et al (2005) Potent mechanism-based inhibitors for matrix metalloproteinases. J Biol Chem 280:33992–34002CrossRefPubMed Ikejiri M, Bernardo MM, Bonfil RD, Toth M, Chang M, Fridman R et al (2005) Potent mechanism-based inhibitors for matrix metalloproteinases. J Biol Chem 280:33992–34002CrossRefPubMed
16.
Zurück zum Zitat Krüger A, Arlt MJ, Gerg M, Kopitz C, Bernardo MM, Chang M et al (2005) Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 65:3523–3526CrossRefPubMed Krüger A, Arlt MJ, Gerg M, Kopitz C, Bernardo MM, Chang M et al (2005) Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 65:3523–3526CrossRefPubMed
17.
Zurück zum Zitat Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY et al (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25:6401–6408CrossRefPubMed Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY et al (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25:6401–6408CrossRefPubMed
18.
Zurück zum Zitat Cui J, Chen S, Zhang C, Meng F, Wu W, Hu R et al (2012) Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener 7:21CrossRefPubMedPubMedCentral Cui J, Chen S, Zhang C, Meng F, Wu W, Hu R et al (2012) Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener 7:21CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Ota R, Kurihara C, Tsou TL, Young WL, Yeghiazarians Y, Chang M et al (2009) Roles of matrix metalloproteinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab 29:1547–1558CrossRefPubMedPubMedCentral Ota R, Kurihara C, Tsou TL, Young WL, Yeghiazarians Y, Chang M et al (2009) Roles of matrix metalloproteinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab 29:1547–1558CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Björndahl M, Cao R, Nissen LJ, Clasper S, Johnson LA, Xue Y et al (2005) Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci U S A 102:15593–15598CrossRefPubMedPubMedCentral Björndahl M, Cao R, Nissen LJ, Clasper S, Johnson LA, Xue Y et al (2005) Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci U S A 102:15593–15598CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Björndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Galter D et al (2005) Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 65:9261–9268CrossRefPubMed Björndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Galter D et al (2005) Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 65:9261–9268CrossRefPubMed
22.
Zurück zum Zitat Chung ES, Chauhan SK, Jin Y, Nakao S, Hafezi-Moghadam A, van Rooijen N et al (2009) Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol 175:1984–1992CrossRefPubMedPubMedCentral Chung ES, Chauhan SK, Jin Y, Nakao S, Hafezi-Moghadam A, van Rooijen N et al (2009) Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol 175:1984–1992CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization by macrophage recruitment. J Clin Invest 113:1040–1050CrossRefPubMedPubMedCentral Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization by macrophage recruitment. J Clin Invest 113:1040–1050CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Tang XL, Sun JF, Wang XY, Du LL, Liu P (2010) Blocking neuropilin-2 enhances corneal allograft survival by selectively inhibiting lymphangiogenesis on vascularized beds. Mol Vis 16:2354–2361PubMedPubMedCentral Tang XL, Sun JF, Wang XY, Du LL, Liu P (2010) Blocking neuropilin-2 enhances corneal allograft survival by selectively inhibiting lymphangiogenesis on vascularized beds. Mol Vis 16:2354–2361PubMedPubMedCentral
25.
Zurück zum Zitat Bock F, Onderka J, Hos D, Horn F, Martus P, Cursiefen C (2008) Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye Res 87:462–470CrossRefPubMed Bock F, Onderka J, Hos D, Horn F, Martus P, Cursiefen C (2008) Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye Res 87:462–470CrossRefPubMed
26.
Zurück zum Zitat Zhang H, Hu X, Tse J, Tilahun F, Qiu M, Chen L (2011) Spontaneous lymphatic vessel formation and regression in the murine cornea. Invest Ophthalmol Vis Sci 52:334–338CrossRefPubMedPubMedCentral Zhang H, Hu X, Tse J, Tilahun F, Qiu M, Chen L (2011) Spontaneous lymphatic vessel formation and regression in the murine cornea. Invest Ophthalmol Vis Sci 52:334–338CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Watari K, Nakao S, Fotovati A, Basaki Y, Hosoi F, Bereczky B et al (2008) Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun 377:826–831CrossRefPubMed Watari K, Nakao S, Fotovati A, Basaki Y, Hosoi F, Bereczky B et al (2008) Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun 377:826–831CrossRefPubMed
28.
Zurück zum Zitat Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita T et al (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363–2372CrossRefPubMedPubMedCentral Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita T et al (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363–2372CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31CrossRefPubMed Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31CrossRefPubMed
30.
Zurück zum Zitat Dong Z, Ghabrial M, Katar M, Fridman R, Berk RS (2000) Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 41:4189–4194PubMed Dong Z, Ghabrial M, Katar M, Fridman R, Berk RS (2000) Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 41:4189–4194PubMed
31.
Zurück zum Zitat Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S et al (2001) Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 508:187–190CrossRefPubMed Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S et al (2001) Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 508:187–190CrossRefPubMed
32.
Zurück zum Zitat Dushku N, John MK, Schultz GS, Reid TW (2001) Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol 119:695–706CrossRefPubMed Dushku N, John MK, Schultz GS, Reid TW (2001) Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol 119:695–706CrossRefPubMed
33.
Zurück zum Zitat Maguen E, Zorapapel NC, Zieske JD, Ninomiya Y, Sado Y, Kenney MC (2002) Extracellular matrix and matrix metalloproteinase changes in human corneas after complicated laser-assisted in situ keratomi-leusis (LASIK). Cornea 21:95–100CrossRefPubMed Maguen E, Zorapapel NC, Zieske JD, Ninomiya Y, Sado Y, Kenney MC (2002) Extracellular matrix and matrix metalloproteinase changes in human corneas after complicated laser-assisted in situ keratomi-leusis (LASIK). Cornea 21:95–100CrossRefPubMed
34.
Zurück zum Zitat Detry B, Erpicum C, Paupert J, Blacher S, Maillard C, Bruyère F et al (2012) Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase. Blood 119:5048–5056CrossRefPubMed Detry B, Erpicum C, Paupert J, Blacher S, Maillard C, Bruyère F et al (2012) Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase. Blood 119:5048–5056CrossRefPubMed
35.
Zurück zum Zitat Ueda M, Terai Y, Kumagai K, Ueki K, Kanemura M, Ueki M (2001) Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells. Int J Cancer 91:778–782CrossRefPubMed Ueda M, Terai Y, Kumagai K, Ueki K, Kanemura M, Ueki M (2001) Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells. Int J Cancer 91:778–782CrossRefPubMed
36.
Zurück zum Zitat Ueda M, Terai Y, Kumagai K, Ueki K, Yamaguchi H, Akise D et al (2001) Vascularendothelial growth factor-C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol 82:162–166CrossRefPubMed Ueda M, Terai Y, Kumagai K, Ueki K, Yamaguchi H, Akise D et al (2001) Vascularendothelial growth factor-C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol 82:162–166CrossRefPubMed
38.
Zurück zum Zitat Hadass O, Tomlinson BN, Gooyit M, Chen S, Purdy JJ, Walker JM et al (2013) Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury. PLoS One 8:e76904CrossRefPubMedPubMedCentral Hadass O, Tomlinson BN, Gooyit M, Chen S, Purdy JJ, Walker JM et al (2013) Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury. PLoS One 8:e76904CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Yu F, Kamada H, Niizuma K, Endo H, Chan PH (2008) Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma 25:184–195CrossRefPubMedPubMedCentral Yu F, Kamada H, Niizuma K, Endo H, Chan PH (2008) Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma 25:184–195CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Ebrahem Q, Chaurasia SS, Vasanji A, Qi JH, Klenotic PA, Cutler A et al (2010) Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am J Pathol 176:496–503CrossRefPubMedPubMedCentral Ebrahem Q, Chaurasia SS, Vasanji A, Qi JH, Klenotic PA, Cutler A et al (2010) Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am J Pathol 176:496–503CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Ji RC (2012) Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell Mol Life Sci 69:897–914CrossRefPubMed Ji RC (2012) Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell Mol Life Sci 69:897–914CrossRefPubMed
42.
Zurück zum Zitat Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH et al (2007) The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96:541–545CrossRefPubMed Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH et al (2007) The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96:541–545CrossRefPubMed
43.
Zurück zum Zitat Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C (2008) Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol 246:115–119CrossRefPubMed Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C (2008) Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol 246:115–119CrossRefPubMed
44.
Zurück zum Zitat Ueda M, Hung YC, Terai Y, Kanda K, Kanemura M, Futakuchi H et al (2005) Vascular endothelial growth factor-C expression and invasive phenotypein ovarian carcinomas. Clin Cancer Res 11:3225–3232CrossRefPubMed Ueda M, Hung YC, Terai Y, Kanda K, Kanemura M, Futakuchi H et al (2005) Vascular endothelial growth factor-C expression and invasive phenotypein ovarian carcinomas. Clin Cancer Res 11:3225–3232CrossRefPubMed
45.
Zurück zum Zitat Zhao T, Zhao W, Meng W, Liu C, Chen Y, Sun Y (2014) Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis. Am J Physiol Heart Circ Physiol 306:H789–796CrossRefPubMedPubMedCentral Zhao T, Zhao W, Meng W, Liu C, Chen Y, Sun Y (2014) Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis. Am J Physiol Heart Circ Physiol 306:H789–796CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Zheng SQ, Huang RQ, Zhang YJ (2010) Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer. Zhonghua Bing Li Xue Za Zhi 39:240–244PubMed Zheng SQ, Huang RQ, Zhang YJ (2010) Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer. Zhonghua Bing Li Xue Za Zhi 39:240–244PubMed
47.
Zurück zum Zitat Zhang HH, Qi F, Zu XB, Cao YH, Miao JG, Xu L et al (2012) A proteomic study of potential VEGF-C-associated proteins in bladder cancer T24 cells. Med Sci Monit 18:BR441–449PubMedPubMedCentral Zhang HH, Qi F, Zu XB, Cao YH, Miao JG, Xu L et al (2012) A proteomic study of potential VEGF-C-associated proteins in bladder cancer T24 cells. Med Sci Monit 18:BR441–449PubMedPubMedCentral
Metadaten
Titel
Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis
verfasst von
Hai-Tao Du
Ling-Ling Du
Xian-Ling Tang
Hong-Yan Ge
Ping Liu
Publikationsdatum
01.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 8/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3651-8

Weitere Artikel der Ausgabe 8/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Open Access 22.02.2024 | Peeling | Originalien

Selektive Vitalfarbstoffe in der Makulachirurgie

Erhöhen sie die Wahrscheinlichkeit der intraoperativen ILM-Identifizierung auch bei einem erfahrenen Operateur?

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.